GlassScriptPhysician profile
Henry Fernandez
NPI 1881698157
$646.09
in general payments reported to CMS, 2019-2025
12 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.16 · 2020: $38.83 · 2021: $46.72 · 2022: $57.13 · 2023: $187 · 2024: $67.13 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.25 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $270.23 | 2020-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $141.61 | 2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Therapeuticsmd, INC. | $56.92 | 2019-2022 | |
| Myovant Sciences INC. | $30.43 | 2021 | |
| Abbvie INC. | $26.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.89 | 2025 | |
| Ethicon US, LLC | $21.42 | 2023 | Enseal |
| Meditrina | $17.00 | 2023 | |
| Avion Pharmaceuticals | $15.44 | 2022 | |
| Scynexis, INC. | $14.14 | 2022 | |
| Urovant Sciences INC | $13.95 | 2022 | |
| Pfizer INC. | $13.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.